**Employers Only Event**

This employer-only strategy roundtable will focus on practical approaches to managing oncology specialty pharmacy spend while preserving quality and access.

Discussion topics will include:

• Biosimilar adoption strategies and contracting implications
• Site-of-care optimization (hospital outpatient vs. infusion centers vs. home)
• White bagging, brown bagging, and provider resistance
• Medical vs. pharmacy benefit alignment
• CAR-T and gene therapy financial exposure
• Stop-loss considerations and high-cost claim risk mitigation
• Transparency challenges with PBMs and specialty pharmacies
• PSG Report Discussion

Confidential peer dialogue. 

Facilitator

Sarah Fleming, PharmD

Senior Pharmacy Benefit Clinical Consultant

Pharmacy Benefits Consulting (PSG)

Vice President, Clinical Strategy

Pharmacy Benefits Consulting (PSG)